Literature DB >> 14692530

Granulocytic sarcoma: an unusual complication of aleukemic myeloid leukemia causing spinal cord compression. A case report and literature review.

Daniel M Landis1, David M Aboulafia.   

Abstract

Granulocytic sarcoma (chloroma) is a rare solid tumor resulting from the proliferation of myelogenous leukemia cells. Chloromas usually present as soft tissue or bony masses of the head and neck in patients with acute myelogenous leukemia (AML) of the French-American-British M2 subtype. Occasionally chloromas may occur in patients with myelodysplasia and other myeloproliferative disorders and rarely precede the development of systemic disease. It is distinctly rare for such tumors to cause epidural compression as a first manifestation of disease. Herein, we report the case of a man with a thoracic extradural chloroma whose presentation of progressive lumbar pain ultimately led to the diagnosis of M2 AML. Surgical intervention prior to the onset of paraplegia and the prompt initiation of chemotherapy resulted in an excellent neurological and hematological outcome. We also review the literature of previously reported cases of spinal cord-associated chloroma and focus on the clinical presentation and treatment of this disorder.

Entities:  

Mesh:

Year:  2003        PMID: 14692530     DOI: 10.1080/1042819031000104051

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  17 in total

1.  Isolated biliary granulocytic sarcoma followed by acute myelogeneous leukemia with multilineage dysplasia: a case report and literature review.

Authors:  Chang Ohk Sung; Young Hyeh Ko; Cheol Keun Park; Kee Taek Jang; Jin Seok Heo
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

2.  Acute myeloid leukemia presenting with complete paraplegia and bilateral total blindness due to central nervous system involvement.

Authors:  Kohta Asano; Hidetaka Wakabayashi; Naohisa Kikuchi; Hironobu Sashika
Journal:  Spinal Cord Ser Cases       Date:  2016-04-07

3.  Unusual case of paraplegia.

Authors:  Prem Amalraj; S Syamlal
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

4.  Granulocytic sarcoma with compressive myelopathy: a rare presentation of chronic myelogenous leukemia.

Authors:  Abhijeet P Ganapule; Auro Viswabandya; Anita Jasper; Palak Patel; Gautami Kokil
Journal:  J Clin Diagn Res       Date:  2014-07-20

5.  Spinal epidural granulocytic sarcoma in non-leukemic patient.

Authors:  Darko Antic; Srdan Verstovsek; Ivo Elezovic; Dana Grujicic; Mirjana Gotic; Jelena Bila; Maja Perunicic; Ljubomir Jakovic
Journal:  Int J Hematol       Date:  2008-12-26       Impact factor: 2.490

Review 6.  Granulocytic sarcoma: an unusual cause of spinal cord compression.

Authors:  Enrico Balleari; Serena Panarello; Elisabetta Capello; Marco Grosso; Caterina Passalia; Paola Pitto; Francesca Raggi; Luca Roccatagliata; Francesco Cabiddu; Riccardo Ghio
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

7.  Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemia.

Authors:  Mhairi Mitchell; Doha Itani; Jonathan Gerber; Nilanjan Ghosh; Ivana Gojo; Amer Zeidan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-10

8.  Myeloid sarcoma presenting as a recurrent, multifocal nerve root entrapment syndrome.

Authors:  Wiebe C Verra; Tom J Snijders; Tatjana Seute; K Sen Han; H Karel Nieuwenhuis; Geert Jan Rutten
Journal:  J Neurooncol       Date:  2008-08-19       Impact factor: 4.130

9.  Acute myeloid leucaemia presenting as a rapidly progressive polyradiculoneuropathy.

Authors:  Claire L Hirst; Mark Willis; Hussain Hussain; Rob Powell
Journal:  BMJ Case Rep       Date:  2015-11-18

Review 10.  Diagnosis and surgical treatment of primary isolated aggressive lumbar myeloid sarcoma: a rare case report and review of the literatures.

Authors:  Cheng-Rui Bai; Xiang Li; Jing-Shi Wang; Jin-Jun Li; Ning Liu; Qi Fei; Dong Li; Yong Yang
Journal:  BMC Musculoskelet Disord       Date:  2021-02-24       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.